Mayo Clinic

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).

2,844 total trials 544 currently recruiting 1816 completed early-phase tilt top decile by trial count

Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.

Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.

Top-decile sponsor footprint

Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

2,844 total, page 41 of 57

COMPLETED NA

Application for Self-Monitoring of Cardiovascular Risk

NCT01883050

COMPLETED Phase 1

Panchromoendoscopy Using Oral Indigo Carmine Mixed With Polyethylene Glycol Prep

NCT01901510

COMPLETED

NIRS Predict Low Cardiac Output State in Neonates and Infants in Cardiac Surgery

NCT01849120

COMPLETED Phase 4

Tailored Antiplatelet Therapy Following PCI

NCT01742117

COMPLETED Phase 1

Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer

NCT01846091

COMPLETED Phase 1

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

NCT01722305

COMPLETED Phase 1

MSC for Occlusive Disease of the Kidney

NCT01840540

COMPLETED Phase 4

Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients

NCT01834404

COMPLETED Phase 1

Plasma Triglyceride Extraction by The Muscle

NCT01860911

COMPLETED NA

Second Echelon Node Study With Methylene Blue

NCT01823172

COMPLETED Phase 2

Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis

NCT01732445

COMPLETED NA

Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study

NCT01834716

COMPLETED Phase 1

Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer

NCT01893294

COMPLETED Phase 2

Physical Activity and Health Outcomes

NCT01833507

COMPLETED

"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones

NCT01619735

COMPLETED Phase 1

Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients

NCT01750905

COMPLETED

Histological Characterization of Vaginal Cuff Tissue Using Different Energy Sources During Robotic Hysterectomy

NCT01846858

COMPLETED NA

Post Operative Pain Control Using Ropivacaine and the ON-Q System in the Adult Pectus Excavatum Patient

NCT01816477

COMPLETED

Vascular Function and Uterine Fibroids

NCT02123069

TERMINATED

Prognostic Value of Aβ Imaging in NPH Prior to Shunt Placement

NCT01834625

COMPLETED

Diagnosis of Subclinical Urinary Tract Infections Using Advanced Microbiome Survey Techniques in High Risk Trauma Patients

NCT01834391

COMPLETED Phase 2

Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions

NCT01834729

COMPLETED

Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease

NCT01809613

COMPLETED NA

Comparison of Three Surgical Techniques to Achieve Patella Symmetry During Resection

NCT01822574

COMPLETED

Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?

NCT01865825

COMPLETED NA

Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation (ProCCESs AWARE)

NCT02039297

COMPLETED Phase 2

Colchicine and CRP in Atrial Fibrillation and AF Ablation

NCT01755949

COMPLETED

Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects

NCT01808053

COMPLETED Phase 1

The Impact of Proton Pump Inhibitors on the Fecal Microbiome

NCT01822977

COMPLETED Phase 1

Vaginal Bromocriptine for Treatment of Adenomyosis

NCT01821001

COMPLETED Early Phase 1

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

NCT01825902

COMPLETED NA

Procalcitonin Use in Pneumonia Patients in the Critical Care Setting

NCT01788488

COMPLETED NA

Feasibility Study for a Web Based Health Coaching Program

NCT01797510

COMPLETED Phase 1

The Effect of Mixed Exercise and Metabolic Stress in Relationship to Age in Healthy Men

NCT01800370

TERMINATED NA

RCT of the Double Wire Technique for Sphincterotomy

NCT01792466

COMPLETED Phase 2

Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes

NCT01700049

COMPLETED

Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy

NCT01777802

COMPLETED Phase 1

The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms

NCT01780519

COMPLETED NA

Arterial Spin Labeling MRI Focal Abnormalities in Refractory Epilepsy

NCT01772654

COMPLETED NA

Long-Term Outcome Following the Treatment of Pediatric Scoliosis

NCT01760434

COMPLETED NA

A Randomized Study of Approaches in Total Hip Arthroplasty

NCT01613508

COMPLETED NA

The Effect of Meditation and Massage Therapy for Breast Cancer Patients Undergoing Tissue Reconstruction

NCT01736605

COMPLETED

Kinetics of Troponin and BNP in Breast Cancer Chemotherapy With Adriamycin and Trastuzumab

NCT01771549

COMPLETED Phase 4

Varenicline for Light Smokers

NCT01639560

TERMINATED Phase 2

Feasibility Study of IV Recombinant Tissue Plasminogen Activator (rtPA) vs. Primary Endovascular Therapy for Acute Ischemic Stroke

NCT01869478

COMPLETED Phase 3

Omega-3 Fatty Acids and Insulin Sensitivity

NCT01686568

COMPLETED

Classification of Breast Masses Based on Visco-elastic Properties Using SAVE Method

NCT04841252

COMPLETED Phase 2

Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant

NCT01706666

COMPLETED Phase 3

Effect of Mindful Eating on Body Mass Index in Obese Adolescents

NCT01764113

COMPLETED NA

Shared Decision Making in Graves Disease - Graves Disease (GD) Choice

NCT02107794

← Previous Page 41 of 57 Next →

Phase Distribution

PhaseTrial count
Phase 1 435
Phase 2 386
Phase 3 86
Phase 4 166

What is open in the Mayo Clinic pipeline

544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).

Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).

Top condition: Healthy (36 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.